Literature DB >> 16387413

Erectile dysfunction and premature ejaculation are the most frequently self-reported sexual concerns: profiles of 9,536 men calling a helpline.

Stamatis Papaharitou1, Loukas Athanasiadis, Evangelia Nakopoulou, Paraskevi Kirana, Alexandra Portseli, Maria Iraklidou, Konstantinos Hatzimouratidis, Dimitrios Hatzichristou.   

Abstract

OBJECTIVES: To describe the range of sexual problems, as reported by men calling a help-line and to investigate factors associated with help seeking behaviour.
METHODS: The study included all calls between 1999 and 2004. The information used for analysis comprised caller's demographic characteristics, the sexual problem reported, previous doctor contacts, coexisting physical and mental health problems.
RESULTS: Erectile dysfunction (ED) and premature ejaculation (PE) were the most frequently reported problems (57 and 19.2% respectively). ED-reporting callers were older (OR 0.63 for the ages of 50-59 yrs), with co-morbidities (OR 1.75) and in stable relationship (OR 0.46), while PE-reporting callers were younger (OR 5.83 for the ages of 20-29 yrs), relatively healthy and more likely single (OR 2.62 and OR 2.92 respectively). Type and duration of sexual concern, age, coexisting health problems and marital status relate significantly (p<0.01) with willingness to seek medical help.
CONCLUSIONS: The study demonstrates that ED and PE are men's major sexual concerns with personal and interpersonal factors influencing their help-seeking behaviour. Help-lines can serve as a link between health services and callers, while provide useful information for policy formation and improvement of support services.

Entities:  

Mesh:

Year:  2005        PMID: 16387413     DOI: 10.1016/j.eururo.2005.09.023

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  11 in total

1.  Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Carol L Link; John B McKinlay
Journal:  Eur Urol       Date:  2007-03-16       Impact factor: 20.096

2.  Relative contributions of modifiable risk factors to erectile dysfunction: results from the Boston Area Community Health (BACH) Survey.

Authors:  Varant Kupelian; Andre B Araujo; Gretchen R Chiu; Raymond C Rosen; John B McKinlay
Journal:  Prev Med       Date:  2009-11-24       Impact factor: 4.018

Review 3.  Looking to the future for erectile dysfunction therapies.

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 4.  How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment.

Authors:  Konstantinos Hatzimouratidis; Dimitrios Hatzichristou
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 5.  Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?

Authors:  Konstantinos Hatzimouratidis
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

6.  Self-Reported Prevalence of and Attitudes toward Premature Ejaculation in a Community-Based Study of Married Couples.

Authors:  Insang Hwang; Dong-Ouk Yang; Kwangsung Park
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

7.  Health-Seeking Behavior for Erectile Dysfunction in Methadone Maintenance Treatment Patients.

Authors:  Fitri Fareez Ramli; Ahmad Nazrun Shuid; Rashidi Mohamed Pakri Mohamed; Tg Mohd Ikhwan Tg Abu Bakar Sidik; Isa Naina Mohamed
Journal:  Int J Environ Res Public Health       Date:  2019-11-01       Impact factor: 3.390

Review 8.  Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Konstantinos Hatzimouratidis
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

Review 9.  The office management of ejaculatory disorders.

Authors:  Bang-Ping Jiann
Journal:  Transl Androl Urol       Date:  2016-08

10.  Development and single dose clinical pharmacokinetics investigation of novel zein assisted- alpha lipoic acid nanoencapsulation of vardenafil.

Authors:  Osama A A Ahmed
Journal:  Sci Rep       Date:  2018-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.